Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

October 01, 1985; Volume 28,Issue 4
  • You have access
    Competitive binding kinetics in ligand-receptor-competitor systems. Rate parameters for unlabeled ligands for the formyl peptide receptor.
    L A Sklar, J Sayre, V M McNeil and D A Finney
    Molecular Pharmacology October 1985, 28 (4) 323-330;
  • You have access
    Phosphatidate and monooleylphosphatidate inhibition of fibroblast adenylate cyclase is mediated by the inhibitory coupling protein, Ni.
    M A Proll, R B Clark and R W Butcher
    Molecular Pharmacology October 1985, 28 (4) 331-337;
  • You have access
    Differentiation between amine transport and beta-adrenergic receptor-mediated binding in cultured mammalian cells.
    P G Lysko and R C Henneberry
    Molecular Pharmacology October 1985, 28 (4) 338-347;
  • You have access
    Phasic ion channel blockade. A kinetic model and parameter estimation procedure.
    C F Starmer and A O Grant
    Molecular Pharmacology October 1985, 28 (4) 348-356;
  • You have access
    Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver.
    M Gillner, J Bergman, C Cambillau, B Fernström and J A Gustafsson
    Molecular Pharmacology October 1985, 28 (4) 357-363;
  • You have access
    Purification and characterization of some metabolic effects of S-neplanocylmethionine.
    B T Keller, R S Clark, A E Pegg and R T Borchardt
    Molecular Pharmacology October 1985, 28 (4) 364-370;
  • You have access
    Rates of pentose cycle flux in perfused rat liver. Evaluation of the role of reducing equivalents from the pentose cycle for mixed-function oxidation.
    S A Belinsky, L A Reinke, R Scholz, F C Kauffman and R G Thurman
    Molecular Pharmacology October 1985, 28 (4) 371-376;
  • You have access
    One-electron redox reactions of pyrazolin-5-ones. A pulse radiolysis study of antipyrine and analogues.
    S V Jovanovic, P Neta and M G Simic
    Molecular Pharmacology October 1985, 28 (4) 377-380;
  • You have access
    Rabbit lung flavin-containing monooxygenase. Purification, characterization, and induction during pregnancy.
    D E Williams, S E Hale, A S Muerhoff and B S Masters
    Molecular Pharmacology October 1985, 28 (4) 381-390;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 28, Issue 4
1 Oct 1985
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics